Table 1: Clinical and demographic characteristics of the patients included in the study.

Characteristics

Total of patients (n = 57), n (%)

Age, median value (range), years

73.7 (interquartile range 14)

Tumor size

T2

T3

T4b

 

35 (61.4)

3 (5.3)

19 (33.3)

Regional lymph nodes

N0

N1

N2a

 

33 (57.9)

20 (35.1)

4 (7.0)

Clinical stages

IIA

IIB

IIIA

IIIB

 

23 (40.3)

14 (24.6)

1 (1.8)

19 (33.3)

Histology grade

1

2

3

 

17 (29.8)

39 (68.4)

1 (1.8)

Tumor histology

Ductal NOS/NST

Pure ductal

Lobular

Mucinous

Tubular

Others

 

28 (49.1)

11 (19.3)

2 (3.5)

12 (21.0)

1 (1.8)

3 (5.3)

Estrogen receptors

Positive > 80%

 

57 (100)

Progesterone receptors

Negative

Positive < 80%

Positive > 80%

 

2 (3.5)

27 (47.4)

28 (49.1)

Ki67

< 20%

21-50%

No data

 

48 (84.2)

8 (14.0)

1 (1.8)